News
1d
Zacks Investment Research on MSNWill AbbVie's Acquisition Spree Aid Pipeline Growth?AbbVie ABBV has been actively ramping up its deal-making efforts lately, thereby strengthening its pipeline. While immunology ...
LLY's $1.3 billion Verve deal marks its third M&A in 2025 as it pushes to diversify across cardiovascular, neuro and cancer ...
LLY’s Stock Price, Valuation and Estimates Shares of Eli Lilly have risen 1.7% so far this year against the industry ’s decline of 1.2%. The stock has also outperformed the sector and S&P 500 ...
16d
Zacks Investment Research on MSNVerve Therapeutics Stock Soars 76% on $1.3B Buyout Offer From LillyVerve Therapeutics VERV signed a definitive agreement with pharma bigwig Eli Lilly LLY. Per the terms, the pharma giant will acquire all outstanding shares of VERV for $10.50 per share in cash, ...
Sanofi and Blueprint Medicines Corporation (Blueprint), a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other ...
In certain diseases, mutations in KIT and PDGFRA force protein kinases into an increasingly active state and Ayvakit/Ayvakyt is designed to bind and inhibit these proteins.
Sanofi has agreed to acquire Blueprint Medicines for up to approximately $9.5 billion, the companies said today, in a deal designed to expand the buyer’s rare immunological disease portfolio ...
PDGFRA mutations are also common and affect a similar signaling pathway. These mutations often result in tumors that behave a bit differently and may respond differently to treatment [11].
Next, the team tested the activity of four PDGFRA inhibitors (dasatinib, crenolanib, axitinib, and avapritinib) against a panel of glioma cell lines with PDGFRA alterations.
The PDGFRA changes in high-grade gliomas lead to increased aggressiveness and growth, but at the same time create a target for effective therapeutic strategies." Johannes Gojo, study leader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results